NCT05683418 2025-07-22A Study to Evaluate the Safety and Tolerability of TOS-358 in Adults With HR+ Breast Cancer and Other Select Solid TumorsTotus MedicinesPhase 1 Recruiting241 enrolled
NCT01226316 2025-06-29Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment SchedulesAstraZenecaPhase 1 Completed285 enrolled
NCT04774952 2025-04-15Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid TumorsRevolution Medicines, Inc.Phase 1 Completed58 enrolled
NCT04586335 2024-03-21Study of CYH33 in Combination With Olaparib an Oral PARP Inhibitor in Patients With Advanced Solid Tumors.Haihe Biopharma Co., Ltd.Phase 1 Terminated24 enrolled